関連する実験動画
Updated: Sep 9, 2025

07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
18.3K
パクリタキセル誘発の周辺神経疾患と生活の質:MICHEL研究によるサブ分析
Aya Sawa1, Riko Sato1, Tomohei Matsuo1
1Department of Breast-Thyroid-Endocrine Surgery, University of Tsukuba Hospital, Ibaraki, Japan.
Anticancer research
|August 28, 2025
まとめ
パクリタキセルによる化学療法による周辺神経症 (CIPN) は,日常活動に大きな影響を及ぼします. この研究ではミロガバリンは
科学分野:
- 腫瘍学
- 神経学
- 薬理学について
背景:
- パクリタキセルは乳がんの一般的な化学療法で,化学療法による周辺神経症 (CIPN) を引き起こします.
- CIPNは,患者の日常生活の活動を著しく阻害します.
- MICHEL研究では,CIPNに対するミロガバリンの有効性を調査した.
研究 の 目的:
- パクリタキセル治療を受けている乳がん患者の日常活動に対するCIPNの影響を分析する.
- CIPNの進行を示す急性変化を特定する.
- CIPNの日常生活への影響に関する患者報告のアンケートによる二次エンドポイントを評価する.
主な方法:
- MICHEL試験試験の予期的な,単一アーム,オープンラベルのサブ分析.
- パクリタキセル治療中のグレード2+CIPNの乳がん患者20人が登録されました.
- 患者の神経毒性アンケートスコアと日常生活活動の中断を評価した.
主要な成果:
- パクリタキセル誘発のCIPNは,特に細部運動能力 (例えば,服のボタン付け) と運動能力 (例えば,階段を登り,歩く) に影響した.
- 5週目では,着物のボタン付け (55%),書くこと (45%),歩くこと (45%) が最も影響を受けた.
- 日常活動が改善したと報告した患者もいます.
結論:
- パクリタキセル誘発のCIPNは,手機能と運動能力に大きく影響し,日常生活に影響を及ぼします.
- ドゥロキセチンやリハビリテーションを含む個別化されたケア戦略は,CIPNの症状を管理するのに役立ちます.
- ミロガバリンの有効性とCIPNの最適な管理を確認するには,さらなる研究が必要です.
関連する概念動画
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
34
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
34
Peripheral Artery Disease IV: Nursing Management
43
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
43
Peripheral Artery Disease I: Introduction
32
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
32
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Peripheral Artery Disease V: Postoperative Nursing Management
24
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
24

